Results 121 to 130 of about 4,248,796 (240)

Long‐term outcomes for mechanical failure and revision following primary gender‐affirming penile prosthesis insertion

open access: yesBJU International, EarlyView.
Objectives To evaluate revision surgery for mechanical failure and overall revision rates of inflatable penile prostheses (IPPs) in assigned female‐at‐birth (AFAB) individuals. Patients and Methods This was a retrospective cohort study of all AFAB patients who underwent primary IPP implantation between September 2001 and July 2024.
Wai Gin Lee   +6 more
wiley   +1 more source

Catheterisation after urethral lengthening in transgender/gender‐diverse individuals: a randomised controlled trial (Safe Access for Bladder Entry in Transgender Men Following Penile Reconstruction [SAFE])

open access: yesBJU International, EarlyView.
Objective To conduct a randomised controlled trial (RCT) to assess the efficacy of the Urethrotech urethral catheterisation device (UCD®; Urethrotech Ltd., Kingston Upon Thames, Surrey, UK) catheter compared to a standard Foley catheter for catheterisation in post‐phalloplasty transgender and gender diverse (TGD) individuals following urethral ...
Anastasia Frost   +4 more
wiley   +1 more source

Health‐related quality of life and patient‐reported outcome measures in economic evaluation of urological technologies: challenges and opportunities

open access: yesBJU International, EarlyView.
Objective To examine the role of health‐related quality of life (HRQoL) assessments and patient‐reported outcome measures (PROMs) in the economic evaluation of urological interventions, highlighting methodological challenges, and identifying areas for future development.
Mohammed El Bahnasawi   +4 more
wiley   +1 more source

Symptom‐guided reduction of BCG dwell time: findings from the north‐REG randomized trial

open access: yesBJU International, EarlyView.
Objectives To evaluate the impact of personalized dwell‐time (DT) reductions on symptom prevalence and systemic toxicities in patients undergoing Bacillus Calmette–Guérin (BCG) instillation for non‐muscle invasive bladder cancer (NMIBC). Methods Within a multinational randomized controlled trial (North‐REG Dwell Time Study [NCT04701151]), 225 patients ...
Lene Munk   +15 more
wiley   +1 more source

Bladder washing cytology in the initial evaluation of patients with neuro‐urological disorders: to do or not to do?

open access: yesBJU International, EarlyView.
Objectives To evaluate if bladder washing cytology (BWC) provides a diagnostic benefit in the initial evaluation of patients with neuro‐urological disorders. Patients and Methods This prospective cross‐sectional study investigated a consecutive series of patients with lower urinary tract symptoms referred for neuro‐urological evaluation at our ...
Fabienne Lehner   +8 more
wiley   +1 more source

Thrombotic risk of urological surgical procedures

open access: yes, 2016
Thromboprophylaxis in urologic procedures is still not a conclusive field. Venous thromboembolism (VTE) is associated with a wide range of risk factors, among them is surgery in general and urologic procedures in particular.
Shyovich, Neta
core  

Diet and risk of bladder cancer: a systematic review of epidemiological evidence

open access: yesBJU International, EarlyView.
Purpose Although tobacco use and occupational exposures are established risk factors for urothelial cancer (UC), the influence of dietary factors remains uncertain. We conducted a systematic review to synthesize evidence from prospective cohort studies examining associations between dietary exposures and UC incidence. Methods A comprehensive literature
Keiichiro Miyajima   +15 more
wiley   +1 more source

Impact of surgical start time on clinical outcomes in urologic surgery: a single-center study of major oncologic surgeries and adrenalectomy. [PDF]

open access: yesWorld J Urol
Kobatake K   +8 more
europepmc   +1 more source

NRF2/xCT‐Mediated Antioxidant Adaptation Attenuates Apoptosis Induced by ASCT2 Inhibition in Prostate Cancer

open access: yesCancer Science, EarlyView.
ASCT2 inhibition induces ROS accumulation and activates NRF2‐dependent xCT upregulation in prostate cancer. This adaptive response partially supports residual cystine acquisition and glutathione synthesis, whereas combined ASCT2 and xCT inhibition disrupts redox compensation and predominantly promotes apoptotic cell death.
Jiaxing Wei   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy